Page last updated: 2024-10-25

chlorpropamide and Brain Vascular Disorders

chlorpropamide has been researched along with Brain Vascular Disorders in 3 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whitehouse, FW1
Fidel, J1
Nelken, L1
Berger, W1

Other Studies

3 other studies available for chlorpropamide and Brain Vascular Disorders

ArticleYear
Two minutes with diabetes.
    Medical times, 1975, Volume: 103, Issue:8

    Topics: Administration, Oral; Anticoagulants; Cerebrovascular Disorders; Chlorpropamide; Diabetes Mellitus;

1975
Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
    Israel journal of medical sciences, 1974, Volume: 10, Issue:7

    Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chlorpropamide; Diabet

1974
[88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969].
    Schweizerische medizinische Wochenschrift, 1971, Jul-17, Volume: 101, Issue:28

    Topics: Age Factors; Cerebrovascular Disorders; Chlorpropamide; Diabetes Mellitus; Diagnosis, Differential;

1971